HealthDay News — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published online January ...
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.
The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback